KOD
KOD
NASDAQ · Biotechnology

Kodiak Sciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$41.01
-2.67 (-6.11%)
As of May 10, 10:08 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target -68.8% upside
Low Target $8.80
Average Target $12.80
High Target $18.52
Current Price $41.01
Current
$41.01
Target
$12.80
$8.80 $12.80 avg $18.52
Scenario Analysis
Bear Case
$8.80
-78.5%
Low target
Base Case
$12.80
-68.8%
Avg target
Bull Case
$18.52
+-54.8%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$47.84
-14.3% from high
52-Week Low
$2.81
+1,359.4% from low
Target vs 52W High
$12.80
-73.2% vs high
Next Earnings Report
May 20, 2026
8d
until earnings
EPS Est: $-1.02
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%